A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

Authors

R. L. Jones
S. P. Chawla
S. Attia
P. Schoffski
H. Gelderblom
B. Chmielowski
A. Le Cesne
B. A. Van Tine
J. C. Trent
R. G. Maki, Zucker School of Medicine at Hofstra/Northwell
+7 additional authors

Publication Date

2019

Journal Title

Cancer

Volume Number

125

Issue Number

14

Pages

2445 - 2454

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Hematology/Medical Oncology

PMID

31034598

DOI

10.1002/cncr.32084